Khiron Life Sciences Corp.

  • instagram
  • LinkedIn
language
English Español Português Deutsch
  • Home
  • Corporate Information
  • Financial Information
  • News & Events
  • Stock Info
  • Investor Insights
  • Governance
  • Webcasts
  • ESG
  • Home
  • Corporate Information
  • Financial Information
  • News & Events
  • Stock Info
  • Investor Insights
  • Governance
  • Webcasts
  • ESG

Press Releases

  • News & Events

  • Overview
  • Press Releases
  • IR Calendar

Khiron begins dispensation of insurance-covered prescriptions in Colombia

Jan 19, 2023 12:42pm EST

NHS reimburses the cost of cannabis treatment to the first ZereniaTM Clinics UK patient

Jan 16, 2023 12:30pm EST

Khiron wins first medical cannabis contract with Colombia's largest public insurance company

Jan 09, 2023 7:45am EST

Government of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis Products

Jan 05, 2023 8:20am EST

Khiron Life Sciences Reports Third Quarter 2022 Financial Results

Nov 30, 2022 8:08am EST

Khiron to Host Third Quarter 2022 Conference Call on November 30, 2022

Nov 18, 2022 7:50am EST

Khiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United Kingdom

Nov 16, 2022 8:00am EST

Khiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital Conference

Sep 13, 2022 11:48am EDT

Khiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from California

Sep 01, 2022 9:20am EDT

Khiron Life Sciences Reports Second Quarter 2022 Financial Results

Aug 29, 2022 8:00am EDT

Khiron to Host Second Quarter 2022 Conference Call on August 29, 2022

Aug 22, 2022 9:20am EDT

Medical Cannabis Leader Khiron Opens Brazil's First Zerenia™ Clinic

Aug 09, 2022 8:15am EDT

Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmaceutical Distribution Capabilities

Aug 02, 2022 6:44pm EDT

Khiron Appoints Helen Bellwood (ACA) as Interim CFO

Jul 18, 2022 8:00am EDT
RSS
  • 1

Investor
Contact

T: 1 (647) 556-5750
investors@khiron.ca

Have a business-related question about KHRN? Or just general inquiries? Send us a message and we'll be happy to help.

Contact Us
CORPORATE PRESENTATION FACT SHEET CONTACTS RSS NEWS FEED
© 2022 Khiron Life Sciences Corp. All Rights Reserved.
Privacy Policy Disclaimer Sitemap